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Abstract
Correlations between pain phenotypes and psychiatric traits such as depression and the personality trait of neuroticism are
not fully understood. In this study, we estimated the genetic correlations of eight pain phenotypes (defined by the UK
Biobank, n= 151,922–226,683) with depressive symptoms, major depressive disorders and neuroticism using the the cross-
trait linkage disequilibrium score regression (LDSC) method integrated in the LD Hub. We also used the LDSC software to
calculate the genetic correlations among pain phenotypes. All pain phenotypes, except hip pain and knee pain, had
significant and positive genetic correlations with depressive symptoms, major depressive disorders and neuroticism. All pain
phenotypes were heritable, with pain all over the body showing the highest heritability (h2= 0.31, standard error= 0.072).
Many pain phenotypes had positive and significant genetic correlations with each other indicating shared genetic
mechanisms. Our results suggest that pain, neuroticism and depression share partially overlapping genetic risk factors.
Introduction
Pain is a global public health priority. In the Global Burden
of Diseases Study 2017, low back and headache disorders
were the leading cause of years lived with disability (YLDs)
worldwide, with neck pain also ranked among the top ten
causes [1]. Some other leading causes of YLDs such as
musculoskeletal disorders and diabetes are also highly likely
to feature pain as a prominent symptom. It was estimated
that 20% of adults suffer from pain globally and that 10%
adults are diagnosed with chronic pain each year [2].
Chronic pain, i.e. pain that has persisted beyond normal
tissue healing time (usually taken as 3 months) can arise
from many causes, but is often idiopathic or difficult to
classify pathophysiologically [3]. It is recognized to have
significant genetic contributions to its development [4].
Improving our understanding of the genetic contributions to
the experience of pain could help our understanding of its
aetiology and prevention. Although some genetic studies
have focused on pain in specific body sites and have sug-
gested possible genetic variants associated with pain phe-
notypes [5], the overall understanding of the genetics of pain
remain unclear. Current limitations in our knowledge
include: 1. the extent to which pain as a phenotype is
determined by additive genetic components mainly repre-
sented by single nucleotide polymorphisms (SNPs); 2.
whether the genetic mechanisms of pain in different body
sites or in different disorders are similar or different; and 3.
whether the genetic connections between pain phenotypes
and other common comorbidities are similar or different.
Addressing these questions brings further challenges when
the severity and the frequency of pain are taken into account.
Both depression and neuroticism (a personality trait) are
common comorbidities of pain [6, 7]. Depression was
ranked as the third most important cause of disability
worldwide and neuroticism was also with significant global
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health impacts [1, 8]. Many pain phenotypes have been
shown to be associated with depression and neuroticism in
epidemiological studies [9–18]. This epidemiological
coexistence could arise in part because of shared genetic
factors [19, 20]. Understanding the genetic correlations
between pain, depression and neuroticism may help to
elucidate their degree of shared genetic architecture and
provide a framework for future causal inference [21]. It has
been proposed that some pain phenotypes (such as
migraine, back pain) and depression or neuroticism share
common genetic components [17, 22–24]. However, to the
best of our knowledge, the genetic correlations between
multiple pain phenotypes in different body sites, and those
between pain phenotypes and depressive symptoms, major
depressive disorders and neuroticism, have not been
reported systematically. Genetic correlation, which refers to
the proportion of variance that two traits share due to
genetic causes, can contribute to the validation of genome-
wide association study (GWAS) results, prediction of traits,
and explaining the underlying aetiologies.
In order to identify genetic correlations between pain
phenotypes and depression and the personality trait of
neuroticism, as well as the genetic correlations among pain
phenotypes, we generated GWAS summary statistics on
eight pain phenotypes in different body sites based on the
UK Biobank cohort and adapted the cross-trait linkage
disequilibrium score regression (LDSC) method through the
LD hub (http://ldsc.broadinstitute.org/ldhub/) and the LDSC
software (https://github.com/bulik/ldsc) [25].
Materials and methods
Participants
Over 500,000 people aged between 40 and 69 years were
recruited by the UK Biobank cohort in 2006–2010 across
England, Scotland and Wales. A detailed clinical, demo-
graphic, and lifestyle questionnaire was completed by all
participants. Biological samples (blood, urine and saliva)
were also provided for future analysis. Further information
on the UK Biobank cohort can be found at www.ukbioba
nk.ac.uk. Ethical approval was granted by the National
Health Service National Research Ethics Service (reference
11/NW/0382). The current study was conducted under
approved UK Biobank data application number 4844.
DNA extraction and quality control (QC) were standar-
dized and the detailed method can be found at http://www.
ukbiobank.ac.uk/wp-content/uploads/2014/04/DNA-Extra
ction-at-UK-Biobank-October-2014.pdf. Genotyping was
obtained from the bespoke Affymetrix UK Biobank chips.
The Wellcome Trust Centre for Human Genetics at Oxford
University was in charge of standard QC procedures for
genotyping results. The detailed QC steps can be found at
http://biobank.ctsu.ox.ac.uk/crystal/refer.cgi?id=155580.
In March 2018, The UK Biobank released an updated
version of the genetic information (including directly gen-
otyped genotypes and imputed genotypes) of 501,708 sam-
ples to all approved researchers. The detailed QC steps of
imputation were described by Bycroft et al. [26].
Definitions of pain phenotypes
We used a specific pain-related questionnaire adapted by the
UK Biobank, which included the question: ‘In the last
month have you experienced any of the following that
interfered with your usual activities?’. The options were: 1.
headache; 2. facial pain; 3. neck or shoulder pain; 4. back
pain; 5. stomach or abdominal pain; 6. hip pain; 7. knee
pain; 8. pain all over the body; 9. none of the above; 10.
prefer not to say. More than one option could be selected.
(UK Biobank Questionnaire field ID: 6159) (http://biobank.
ndph.ox.ac.uk/showcase/refer.cgi?id=100527).
For each pain phenotype, cases were defined as those
who selected the specific pain site option for the above
question, regardless of whether they had selected other
options. For example, headache cases are those who
selected the ‘headache’ option; facial pain cases are those
who selected the ‘facial pain’ option; etc.
For each GWAS analysis, controls were those who
selected the ‘none of the above’ option. Thus we used the
same ‘no pain’ control population for all pain phenotypes in
different body sites.
Definitions of depression and neuroticism
The phenotypes of depression and neuroticism were defined
by the psychological cohorts collected by the LD hub [27–
29]. The original researchers of these cohorts agreed to
share the GWAS summary statistics on depression and
neuroticism with the LD hub for generating genetic corre-
lations. Therefore, we selected the ‘psychiatric diseases’
option and the ‘personality traits’ option in the LD hub to
include the depression and neuroticism traits. These traits
are: depressive symptoms [27], neuroticism (×2 studies)
[27, 28], major depressive disorder [29]. However, for
neuroticism, we only chose the version used by Okbay et al.
[27], as it is a GWAS meta-analysis publication, the results
of which included the results from van den Berg et al. [28].
Statistical analysis
Generating the heritabilities of all pain phenotypes
In this study, genome-wide complex trait analysis was used
to calculate narrow-sense SNP-based heritabilities on a
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liability scale based on the genomic-relatedness-based
restricted maximum-likelihood approach [30].
Generating GWAS summary statistics of all pain
phenotypes
In this study, genotype data were analysed in BGENIE
(https://jmarchini.org/bgenie/), as recommended by UK
Biobank. Routine QC steps included: removing SNPs with
INFO scores <0.1, SNPs with minor allele frequency
<0.5%, or SNPs that failed Hardy–Weinberg tests P < 10−6.
SNPs on the X and Y chromosomes and mitochondrial
SNPs were also removed. We further removed those
whose ancestry was not white British based on principal
component analysis, those who were related at least another
participant in the cohort (a cut-off value of 0.044 in
the generation of the genetic relationship matrix) and those
who failed QC. Association tests based on standard
Frequentist association were performed using BGENIE
adjusting for age, sex, body mass index (BMI), nine
population principal components, genotyping arrays, and
assessment centres.
Generating genetic correlations between pain phenotypes
and depression and neuroticism by the LD hub
The LD hub has gathered 235 published GWAS summary
statistics of different disorders worldwide. Those GWAS
summary statistics were compared against researcher-
uploaded GWAS summary statistics of a phenotype of
interest to generate genetic correlations between the phe-
notype and 235 phenotypes [25].
In order to identify genetic correlations between pain
phenotypes and the depression and neuroticism traits, we
used the cross-trait LDSC method through the LD Hub
v1.9.0 [25]. The LD Hub estimates the bivariate genetic
correlations of a phenotype with other traits using individual
SNP allele effect sizes and the average LD in a region. In
this study, those with P values < 0.001 (0.05/24+ 28, eight
pain phenotypes and three psychiatric phenotypes, plus 28
pair combinations among pain phenotypes) should be con-
sidered significant surviving Bonferroni correction for
multiple testing.
Results
The heritabilities and the GWAS summary statistics
of all pain phenotypes
The specific pain question received 775,252 responses to all
options answered by 501,708 UK Biobank participants
during the initial assessment visit (2006–2010). Table 1
summarises the numbers of cases and controls in the GWAS
of the eight pain phenotypes. A Supplementary Table 1
presenting the age, sex, and BMI of participants contribut-
ing to the eight GWAS and of the non-responders is
included. The GWAS summary statistics can be down-
loaded from the links in the data availability section. The
Manhattan plots and Q–Q plots of these GWAS are also
included in a Supplementary file.
The narrow-sense SNP heritabilities of each pain phe-
notype are presented in the Table 2. Pain all over the body
had the greatest heritability among all pain phenotypes
(h2= 0.31, standard error (SE)= 0.072). Knee pain has the
lowest heritability (h2= 0.08, SE= 0.029).The SNP herit-
abilities of other pain phenotypes were between 0.11 and
0.24.
Genetic correlations between pain and depression
and neuroticism
Through the genetic correlation analysis, we identified
multiple significant and positive correlations between pain
phenotypes and depression and neuroticism. (Table 2,
Fig. 1) A supplementary table is provided to show the
genetic correlations between pain phenotypes and all
available psychiatric and personality traits in the LD hub
(Supplementary Table 2).
Depression and eight pain phenotypes
For depressive symptoms, all pain phenotypes had sig-
nificant and positive genetic correlations with depression
except hip pain and knee pain. The largest genetic cor-
relation occurred with pain all over the body (rg= 0.69,
P= 1.4 × 10−27), followed by stomach or abdominal pain
(rg= 0.67, P= 5.7 × 10−7). For hip pain and knee pain,
although there were positive genetic correlations with
depressive symptoms (rg= 0.34 and 0.12, correspond-
ingly), the associations did not survive Bonferroni cor-
rection (P= 0.03 and 0.13, correspondingly). The values
Table 1 The sample numbers available for GWAS on eight pain
phenotypes
Pain phenotypes Cases Controls
Headache 74,761 149,312
Facial pain 2610 149,312
Neck or shoulder pain 53,994 149,312
Stomach or abdominal pain 8217 149,312
Back pain 43,991 149,312
Hip pain 10,116 149,312
Knee pain 22,204 149,312
Pain all over body 5670 149,312
Genetic correlations between pain phenotypes and depression and neuroticism
of the genetic correlations between other pain phenotypes
and depressive symptoms were between rg= 0.33 and
0.55, and all were statistically significant after adjustment
for multiple testing.
For major depressive disorder, the genetic correlation
results were similar to those for depressive symptoms. The
largest genetic correlation was with stomach or abdominal
pain (rg= 0.53, P= 0.0005), followed by pain all over the
body (rg= 0.43, P= 5.6 × 10−6). However, the rg values of
hip pain and knee pain were 0.04 and −0.07, which were
also statistically insignificant (P= 0.80 and 0.53, corre-
spondingly). The values of the genetic correlations between
other pain phenotypes and major depressive disorder were
between rg= 0.34 and 0.40, and all were statistically
significant.
Neuroticism and eight pain phenotypes
With neuroticism, stomach or abdominal pain had the lar-
gest genetic correlation (rg= 0.70, P= 2.4 × 10−9). Head-
ache followed next with rg= 0.50 and P= 2.2 × 10−72.
All genetic correlations with other pain phenotypes (except
hip pain and knee pain) were positive and significant with rg
values between 0.30 and 0.50. For hip pain and knee pain,
although there were positive genetic correlations with
neuroticism, the correlations were statistically insignificant.
Genetic correlations among pain phenotypes
Through the LDSC software, we identified multiple sig-
nificant and positive correlations among pain phenotypes
Table 2 The SNP-based heritabilities (h2) of eight pain phenotypes from the UK Biobank cohort and their genetic correlations with depressive
symptoms, major depression and neuroticism
Heritability Depressive symptoms Major depressive disorder Neuroticism
Pain phenotypes h2 (SE) P rg P rg P rg P
Headache 0.21 (0.015) 3.9 × 10−45 0.52 (0.036) 1.6× 10−46 0.39 (0.057) 1.6× 10−11 0.50 (0.028) 2.2× 10−72
Facial pain 0.24 (0.12) 0.036 0.33 (0.091) 2× 10−4 0.34 (0.137) 0.01 0.30 (0.068) 1.0× 10−5
Neck or shoulder pain 0.11 (0.017) 4.3 × 10−11 0.55 (0.048) 3.4× 10−30 0.40 (0.073) 5.8× 10−8 0.44 (0.039) 5.3× 10−7
Stomach or abdominal pain 0.14 (0.050) 0.004 0.67 (0.134) 5.7× 10−7 0.53 (0.15) 5× 10−4 0.70 (0.118) 2.4× 10−9
Back pain 0.11 (0.020) 8.4 × 10−9 0.48 (0.063) 1.5× 10−14 0.36 (0.086) 3× 10−5 0.40 (0.054) 1.7× 10−13
Hip pain 0.12 (0.041) 0.005 0.34 (0.16) 0.03 0.04 (0.167) 0.80 0.27 (0.128) 0.04
Knee pain 0.08 (0.029) 0.007 0.12 (0.083) 0.13 −0.07 (0.113) 0.53 0.18 (0.057) 0.002
Pain all over body 0.31 (0.072) 1.3 × 10−5 0.69 (0.063) 1.4× 10−27 0.43 (0.095) 5.6× 10−6 0.45 (0.054) 3.4× 10−17
P values < 0.001 (0.05/24+ 28) were considered as significant for genetic correlations. Those significant rg values were in bold
SE standard error, rg genetic correlation
Fig. 1 The genetic correlations
between eight pain phenotypes
and depressive symptoms, major
depressive disorders and
neuroticism. Please note, the
genetic correlations between
these traits and hip pain and
knee pain were not significant
(P > 0.001, Table 2). rg genetic
correlation
W. Meng et al.
(Table 3, Fig. 2). The largest positive and significant genetic
correlation was between neck or shoulder pain and back
pain (rg= 0.83, P= 2.11 × 10−100), followed by hip pain
and pain all over the body (rg= 0.81, P= 0.0004). Neck or
shoulder pain had positive and significant genetic correla-
tions with all other pain phenotypes (0.52 < rg < 0.83), this
was the same for pain all over the body (0.36 < rg < 0.81).
Among all pain phenotypes, hip pain only had three positive
and significant genetic correlations (neck or shoulder pain,
back pain and pain all over the body) with other pain
phenotypes.
Discussion
In this study, eight self-reported pain phenotypes, from
different sites across the body, were all heritable and
showed a broad pattern of partially shared genetic archi-
tecture with each other. We also found evidence that pain
shared genetic architecture with depressive symptoms,
major depressive disorder and neuroticism for most sites
across the body. Hip pain and knee pain were the exception,
in showing weak and non-significant genetic correlations
with depressive symptoms, major depressive disorder and
neuroticism.
A significant and positive correlation between a pain
phenotype and a psychiatric trait reflects shared genetic
architecture. This can reflect pleiotropy, where specific
genetic alleles increase risk to both phenotypes, but it can
also reflect mediated pleiotropy where there is a directional
or causal association between these traits [21]. It is also
possible for positive genetic correlations to be generated byTa
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Fig. 2 The heatmap of the genetic correlations among eight pain
phenotypes
Genetic correlations between pain phenotypes and depression and neuroticism
misclassification of pain as depression, or vice versa [31]. It
is important to examine whether there is subgroup hetero-
geneity amongst individuals with pain and depression that
can be explained by variation on the other trait. It is worth
mentioning that a genetic correlation between a pain phe-
notype and a psychiatric trait does not necessarily indicate
that a genetic predisposition for a psychiatric trait will
increase sensitivity to pain, or vice versa.
The nature of the relationship between pain phenotypes
and depression has been uncertain. Epidemiological studies
have identified that depression is reported more often by
patients reporting pain and also that pain is a risk factor for
the future development of depression [28]. Pain was present
in around 65% in depressed patients and up to 85% of
patients with chronic pain were affected by severe depres-
sion [32]. Previous studies have reported a genetic corre-
lation between pain and depression of 0.56 (in a sample of
twins) and 0.51 (in a family-based samples) [19, 33].
Although the exact mechanisms linking these conditions
are not clear, genetic mechanisms are implied through
shared biological pathways, such as gene expression
in biological networks, the endocannabinoid system, the
hypothalamic–pituitary–adrenal axis and inflammatory
pathways [34]. Further, imaging studies on brain function
support the relationships between pain phenotypes and
psychiatric traits. Pain has been associated with functional
imaging alterations in brain regions responsible for pro-
cessing emotional stimuli [35]. Our study answered a spe-
cific question about depression: to what extent is each pain
phenotype genetically correlated with depression? Our
genetic correlation results between headache, facial pain,
neck or shoulder pain, stomach or abdominal pain, back
pain, pain all over the body and depression are all consistent
in direction with known epidemiological associations [9–
14]. This suggests that shared genetic risk factors are likely
to partly explain their phenotypic correlations. However, the
genetic correlations between hip pain and knee pain and
depression were contrary to previous observations that
depression and knee pain or hip pain are strongly related
[36]. Previous studies have shown that knee pain from
osteoarthritis increases a person’s risk of developing sub-
sequent depression [37]. A systematic review of the rela-
tionship between knee pain and multiple psychiatric traits
also found an association between depression and knee pain
[38]. While genetic factors may contribute to the pain at
different sites, our findings suggest that non-genetic factors
may be more important in the co-occurrence of knee or hip
pain with depression.
The genetic relationships between pain phenotypes and
neuroticism are also of interest and are similar to those
between pain and depression. Neuroticism was identified to
be a potential risk factor for elevated pain responses in
laboratory pain in healthy children, and can likely
exacerbate pain responses when coupled with fear of bodily
sensations [39]. Neuroticism has also been independently
associated with greater pain catastrophizing [7]. Our genetic
correlation results were consistent with findings from epi-
demiological studies of headache [15], neck or shoulder
pain [16], back pain [17], and pain all over the body [18].
No previous studies have shown epidemiological data for
the relationships between neuroticism and facial pain or
stomach or abdominal pain. It was also suggested from our
study that there were no significant genetic relationships
between knee pain or hip pain and neuroticism. To our
knowledge, no previous studies have specifically examined
the epidemiological relationships between neuroticism and
hip pain or knee pain. Our findings suggest that hip pain
and knee pain may belong to a separate pain group and
should be considered separately when designing studies
of the genetic relationships between pain and psychiatric
disorders.
This paper also reported the genetic correlations among
pain phenotypes in different body sites. Many pain phe-
notypes have positive and significant genetic correlations
with each other indicating the common genetic mechan-
isms behind different pain phenotypes. This common
mechanism is less likely to be represented by a few genes
with large effects, but to reflect many genetic variants with
smaller effects. It is biologically plausible for back pain and
neck or shoulder pain to demonstrate the largest genetic
correlation (rg= 0.83) since causal genetic factors could
have plausible detrimental effects across the whole spine. It
is worth mentioning that neck, shoulder and back pain can
be difficult to locate precisely, and can extend from one
body area to the other; therefore phenotype and sample
overlaps might also contribute to a certain extent. For other
genetic correlations such as that between hip pain and pain
all over the body (rg= 0.81), the reason is less apparent
and merits further research. It is challenging to say that a
specific pain site phenotype is mainly caused by muscu-
loskeletal reasons, vascular issues or neurological factors.
For example, vascular issues play a more important role
than neurological factors in migraine, while considering
multiple headache types as a whole, neurological factors
take the leading role [40, 41]. Back pain is strongly asso-
ciated with musculoskeletal causes, while neurological
factors also contribute a part [42]. Interestingly, as we can
see from the genetic correlation results, different pain
phenotypes have shared genetic correlations. This means it
might not be appropriate to include controls that have pain
in other sites as this might cause false-negative results,
especially for highly and genetically correlated pain phe-
notypes. We used self-reported migraine GWAS data from
23andMe, Inc. as a further pain trait to calculate its genetic
correlations with the UK Biobank pain phenotypes [40]. As
the samples from 23andMe were from the USA, there was
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likely to be no sample overlaps with UK Biobank. The
results supported our main findings in that there were
shared genetic components between pain phenotypes
across these two cohorts (Supplementary Fig. 1). We also
performed a Mendelian randomisation (MR) analysis using
headache as an exposure and psychiatric traits as outcomes
to check if the genetic predisposition to headache also has
causal effects to psychiatric outcomes. In addition, we also
checked whether these psychiatric outcomes have causal
effects to headache. The MR results showed that headache
does have casual effects on depressive symptoms and
neuroticism, but shows no causal effects on major
depressive disorder based on the tradition inverse variance
weighted method [43]. Neuroticism also has causal effects
to headache, while major depressive disorders and
depressive symptoms do not (Supplementary Table 3).
Finally, the shared genetic contribution to pain phenotypes
was further supported by the Mendelian randomisation
analysis, which found that a genetic predisposition to
headache resulted in a greater likelihood of symptoms of
depression and neuroticism (and vice versa with neuroti-
cism). To our knowledge, there have been no previous MR
studies examining causal effects between headache or
migraine and depression or neuroticism. Further work in
this area is required.
The highest narrow-sense heritability among all pain
phenotypes in this study was 0.31 for pain all over the
body. The heritabilities of all other pain phenotypes were
moderate. The narrow-sense heritability does not take
gene–gene interactions, gene–environment interactions,
or the contribution from rare variants into account, and is
therefore likely to be an under estimate of the true herit-
ability. This is the first report of the heritabilities for facial
pain (h2= 0.24), stomach or abdominal pain (h2= 0.14),
to the best of our knowledge, and suggests important
genetic contributions to chronic pain at all body sites.
Arguably the greatest strength of the current study was
the large size of the UK Biobank sample. Large sample
sizes will allow researchers to overcome the potential
issues of small sample sizes and limited study power
(such as sample heterogeneity and sample selection bia-
ses) to cut through the statistical noise. This provided the
largest single sample size for many of the pain phenotypes
studied here compared with previous GWAS studies of
pain [5]. Nevertheless, potential limitations should also be
taken into account. The phenotyping in UK Biobank was
based on a single specific non-standard pain-related
question. This means that all pain phenotypes were
broadly defined and unfiltered by other potentially rele-
vant information on the nature, duration or intensity of the
pain. Similar limitations also apply to the psychological
traits measured in UK Biobank and elsewhere [44].
Currently, a new and more detailed, validated pain-related
questionnaire is being administered to participants in UK
Biobank, and this will allow for more detailed and
focused phenotyping for use in future analyses, again with
very large sample sizes. These can and should further
analysis of the important gender difference in the genetic
contributions to pain traits.
In summary, we have identified significant and positive
genetic correlations between multiple pain phenotypes and
depression and neuroticism, suggesting that the known
associations between these traits are partly due to shared
genetic architecture. In contrast, we have suggested that the
known epidemiological relationships between hip and knee
pain and depression are not caused primarily by common
genetic factors, prompting a search for other explanations.
In addition, we have shown that many pain phenotypes are
heritable and have positive and significant genetic correla-
tions with each other. This indicates that common genetic
risk factors confer liability to pain at many different sites
across the body, suggesting shared risk factors and, poten-
tially, disease mechanisms.
These findings contribute to the understanding of the
genetic and biological mechanisms for individual pain
phenotypes, depression and neuroticism. In addition, the
findings also represent an early but important step towards
the identification of causal associations between pain phe-
notypes and psychiatric disorders and identifying subgroup
heterogeneity.
Data availability
All GWAS summary statistics can be downloaded from
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